GlassScriptPhysician profile
Syed Zaidi
NPI 1801003223
$15,402.15
in general payments reported to CMS, 2019-2025
30 companies · $1,384 in 2025
The $1,384 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,415 · 2020: $1,009 · 2021: $2,605 · 2022: $3,036 · 2023: $2,587 · 2024: $1,366 · 2025: $1,384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,336.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,490.78 | 2021-2025 | Onyx Frontier, Symplicity G3, Telescope |
| Edwards Lifesciences Corporation | $4,131.29 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $1,589.14 | 2019-2025 | Watchman, Watchman Access System, Watchman Flx |
| Abiomed | $829.90 | 2019-2025 | Impella |
| Abbott Laboratories | $667.45 | 2020-2023 | Mitraclip, Amplatzer Amulet |
| Medtronic Vascular, INC. | $324.39 | 2020 | |
| Novo Nordisk INC | $221.76 | 2021-2023 | Ozempic, Rybelsus |
| Shockwave Medical, INC | $220.65 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Terumo Medical Corporation | $196.36 | 2019-2025 | Glidewire, Tr Band, Metacross Otw |
| Penumbra, INC. | $140.35 | 2025 | Indigo System |
| Novartis Pharmaceuticals Corporation | $127.71 | 2022-2025 | |
| Atricure, INC. | $47.33 | 2019-2022 | |
| Pfizer INC. | $36.69 | 2019-2022 | |
| Irhythm Technologies, INC. | $36.16 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| E.R. Squibb & Sons, L.L.C. | $34.56 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $31.48 | 2019-2021 | |
| Teleflex LLC | $31.32 | 2019 | |
| Abbvie INC. | $29.18 | 2023 | Vraylar |
| Celonova Biosciences, INC. | $24.73 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.32 | 2024 | Lifevest |
| Regeneron Healthcare Solutions, INC. | $19.47 | 2019 | |
| W. L. Gore & Associates, INC. | $18.97 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.92 | 2021 | |
| Amarin Pharma, INC. | $18.30 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $17.91 | 2023 | Arcalyst |
| Cardinal Health 200 LLC | $16.60 | 2021 | |
| Scpharmaceuticals INC. | $16.59 | 2024 | |
| Biotronik INC. | $15.90 | 2021 | |
| Ge Healthcare | $14.99 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Zaidi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.